THROMBOPOIESIS-STIMULATING PROTEINS HAVING REDUCED IMMUNOGENICITY

摘要

The present invention relates to variant thrombopoietin proteins that possess thrombopoiesis-stimulating activity and have reduced immunogenicity. In particular, variants of thrombopoietin with reduced ability to bind one or more class II MHC molecules are described.